Treatment of Molluseum Contagiosum with Oral Cimetidine: Clinical Experience in 13 Patients
- 1 July 1996
- journal article
- Published by Wiley in Pediatric Dermatology
- Vol. 13 (4) , 310-312
- https://doi.org/10.1111/j.1525-1470.1996.tb01247.x
Abstract
Our purpose was to determine if oral cimetidine, a histamine‐receptor antagonist, might be of benefit in the treatment of extensive molluseum contagiosum in children. We present 13 pediatric patients in whom conventional treatment modalities for molluseum contagiosum were unsuccessful or difficult to apply. They were treated with a two‐month course of oral cimetidine 40 mg/kg/day. All but three children who completed treatment experienced clearance of all lesions. These children had no new lesions but had persistance of several lesions. One child did not take the drug and did not clear. No adverse effects were observed. We conclude that oral cimetidine may be of benefit in the management of widespread or facial molluseum contagiosum in immunocompetent children.Keywords
This publication has 15 references indexed in Scilit:
- Cimetidine therapy for multiple viral warts in childrenJournal of the American Academy of Dermatology, 1993
- Clinical Relevance of Cimetidine Drug InteractionsDrug Safety, 1992
- Pediatric MastocytosisJournal of Investigative Dermatology, 1991
- In Vivo Anergy Reversal With Cimetidine in Patients With CancerJAMA Otolaryngology–Head & Neck Surgery, 1986
- Modulation of Suppressor-Cell Activity by Cimetidine in Patients with Common Variable HypogammaglobulinemiaNew England Journal of Medicine, 1985
- Cimetidine for Herpes ZosterNew England Journal of Medicine, 1984
- Cimetidine in the Treatment of Hyperimmunoglobulinemia E with Impaired ChemotaxisThe Journal of Infectious Diseases, 1983
- The immune restorative effect of cimetidine administration in vivo on the local graft-versus-host reaction of cancer patientsClinical Immunology and Immunopathology, 1982
- Therapeutic effect of cimetidine in patients undergoing haemodialysis.BMJ, 1979
- EFFECT OF HISTAMINE H2-RECEPTOR ANTAGONISTS ON DELAYED HYPERSENSITIVITYThe Lancet, 1978